NF-KappaB and Its Role in Clear Cell Renal Cell Carcinoma
Author Information
Author(s): Meteoglu Ibrahim, Erdogdu Ibrahim H, Meydan Nezih, Erkus Muhan, Barutca Sabri
Primary Institution: Adnan Menderes University
Hypothesis
The study investigates the role of NF-KappaB (p50 subunit) in clear cell renal cell carcinoma (ccRCC) and its relation to angiogenesis and apoptosis.
Conclusion
The study found that NF-KappaB is associated with markers of angiogenesis and apoptosis in ccRCC, suggesting it could be a potential therapeutic target.
Supporting Evidence
- NF-κB was expressed in 85% of ccRCC patients.
- There was a significant correlation between NF-κB expression and VEGF, EGFR, bc1-2, and p53.
- The study suggests NF-κB could be a target for new cancer treatments.
Takeaway
This study looked at how a protein called NF-KappaB is related to cancer in the kidneys and found that it might help doctors treat this type of cancer better.
Methodology
The study used immunohistochemistry to analyze tissue samples from 40 patients with ccRCC.
Limitations
The study had a small sample size and did not find significant correlations with tumor grade, stage, age, and sex.
Participant Demographics
{"age_range":"35–85","median_age":63,"sex_distribution":{"male":30,"female":10}}
Statistical Information
P-Value
0.001, 0.004, 0.010, 0.037
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website